Merit Financial Group, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1621225
ALPHARETTA, GA
Position in REGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,078,255
-$2,236,936 QoQ
Shares Held
3,333
-40.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#507
of 1,322 holders
Holding Since
Jun 2020
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Merit Financial Group, LLC holds $38,062,980 across 57 Biotechnology names. REGN ranks #4 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,218 | $6,069,041 | |
| 2 | INCY |
Incyte Corp
|
50,561 | $5,731,591 | |
| 3 | EXEL |
Exelixis, Inc.
|
84,634 | $4,604,933 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
3,333 | $2,078,255 | |
| 5 | MRNA |
Moderna, Inc.
|
25,205 | $1,765,104 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
5,380 | $1,296,414 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
20,198 | $1,155,727 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
11,908 | $1,035,397 |
All Filings in REGN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,078,255 | 3,333 | Shares | Other | 2026-07-20 | |
| 2026-03-31 | $4,315,191 | 5,585 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $3,097,512 | 4,013 | Shares | Other | 2026-01-26 | |
| 2025-09-30 | $1,045,256 | 1,859 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $242,550 | 462 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,033,160 | 1,629 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $618,302 | 868 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $837,838 | 797 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $920,702 | 876 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $695,880 | 723 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $287,200 | 327 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $581,009 | 706 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $495,792 | 690 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $294,157 | 358 | Shares | Sole | 2023-04-24 | |
| 2020-06-30 | $210,170 | 337 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||